Rhode Island Economic Policy Council 1 Rhode Island Biopharmaceutical Manufacturing Training Institute: A PRESCRIPTION FOR ECONOMIC GROWTH Southern New England Economic Summit May 10, 2002

Rhode Island Economic Policy Council 2 Biopharmaceutical Manufacturing in Rhode Island The Industry has established a presence in RI: Dow Biopharmaceutical Contract Manufacturing Services Immunex (Amgen) There is a specific and a significant workforce need

Rhode Island Economic Policy Council 3 The Institute - Meeting industry needs The Industry is experiencing unprecedented growth Several hundred manufacturing jobs will be created in RI in the next few years Training of the manufacturing workforce is difficult in a manufacturing environment The Institute will provide hands-on training in an actual production environment (“flight simulator” model)

Rhode Island Economic Policy Council 4 Training Institute Program Timeline July 2001 HRIC planning grant: $25,000 Fall 2001 Industry survey completed Fall 2001 Educational survey completed March 2002 HRIC grant: $300K (3 years)

Rhode Island Economic Policy Council 5 Institute Structure 501 (c)(3) organization supported by corporate training dollars; federal training subsidies; in-kind faculty time, equipment, etc. Entrepreneurial, credentialed executive director from biopharmaceutical industry Dynamic board of directors drawn primarily from the industry

Rhode Island Economic Policy Council 6 Biopharmaceutical Manufacturing Training Institute – Next Steps Funding commitment secured from the HRIC Closing on commitments from private industry The Institute is being established as a 501(c)3 not-for-profit organization Assembling the board of directors National search being conducted for full-time, executive director

Rhode Island Economic Policy Council 7 Executive Director Phase 1 (3-5 years) Build industry-focused educational curriculum Promotion of program within industry Identify funding opportunities Establish dedicated facility for training

Rhode Island Economic Policy Council 8 Implementation Timeline Phase 1 - Raise $10M for construction and equipment of permanent facility and equipment of an interim training facility. Offer training for Dow and Immunex employees at interim facility Phase 2 – Training provided at permanent facility for Immunex, Dow and other regional biopharmaceutical manufacturers

Rhode Island Economic Policy Council 9 BMTI: A Magnet for Future Growth Technology industries co-locate with abundant, highly skilled and affordable workforces Will address immediate needs of local industry Will become a center for biopharmaceutical manufacturing training Will provide a catalyst for future industry growth in Rhode Island and New England